In France’s healthcare system, language accessibility for Braille users is not just a talking point — it’s the law. The French government not only requires the tactile writing system on medication packaging, but also implements rigorous quality control protocols and mandates inclusive pharmacy practices that have revolutionized the meaning of independence for the country’s approximately 2 million blind and visually impaired people.
France’s multi-tiered legislative response to address language accessibility for Braille users stems from a larger effort to modernize pharmaceutical legislation across the European Union (EU). Like all EU member states, France is subject to the European Parliament’s 2004 directive requiring the name and dosage of medicinal products — both prescription and over-the-counter (OTC) —to appear in Braille format on its packaging. This regulation represents the first step in ensuring that blind and visually impaired individuals can independently identify their medications.
France didn’t stop there, however. The country’s national health authorities, Agence Nationale de Sécurité du Médicament (ANSM), encourage the inclusion of medicine form (for example, tablet or capsule) — not just name and dosage — in Braille on packaging. In addition, the Braille used on packaging must conform to the ISO 17351 standard on positioning and durability, which defines specific dot height, spacing, and embossing methods.
Beyond that, France’s rigorous quality control and national inspection protocols are enforced through systems like EyeC Proofile and Schlafender Hase’s TVT to maintain the highest standards. Non-compliant products can be flagged or recalled — a level of scrutiny not uniformly applied across all EU states.
Finally, the country’s 2005 disability law, Loi Handicap, makes accessibility a legal right across all public services, including healthcare. This legislation requires accessible information formats in all healthcare settings and supports Braille literacy and education through public funding. French pharmacies are legally required to provide accessible mediation guides upon request, offer in-person assistance for blind and visually impaired patients, and maintain Braille-labeled stock for both prescription and OTC products.
While other EU member countries may meet the European Parliament’s minimum requirement of Braille on medication packaging, France’s accessibility infrastructure, inspection protocols, and public health commitments make it a standout in terms of real-world accessibility.
